These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients. Am J Cardiol; 1993 Nov 01; 72(14):1031-7. PubMed ID: 8213583 [Abstract] [Full Text] [Related]
3. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience. Beigel Y, Brook G, Eisenberg S, Fainaru M, Harats D, Levy Y, Rubinstein A, Skurnik Y. Isr J Med Sci; 1993 May 01; 29(5):272-7. PubMed ID: 8314685 [Abstract] [Full Text] [Related]
4. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A. Int J Clin Pharmacol Res; 1999 May 01; 19(4):105-16. PubMed ID: 10939028 [Abstract] [Full Text] [Related]
5. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study]. Ferrari P, Weidmann P, Riesen WF, Martius F, Luban S, Pasotti E, Erne P, Fragiacomo C, Noseda G, Reutter F. Schweiz Med Wochenschr; 1993 Sep 18; 123(37):1736-41. PubMed ID: 8211024 [Abstract] [Full Text] [Related]
7. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group. Curr Med Res Opin; 2003 Sep 18; 19(8):689-98. PubMed ID: 14687438 [Abstract] [Full Text] [Related]
15. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group. Am Heart J; 2004 Sep 18; 148(3):447-55. PubMed ID: 15389231 [Abstract] [Full Text] [Related]
17. [Effects of pravastatin on serum lipids, apoproteins, and lipoprotein (a) in primary hypercholesterolemia]. Galetta F, Sampietro T, Basta G, Bionda A. Minerva Med; 1994 Jun 18; 85(6):321-6. PubMed ID: 8084435 [Abstract] [Full Text] [Related]
18. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122 [Abstract] [Full Text] [Related]
19. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep 14; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]